272 related articles for article (PubMed ID: 24478731)
1. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
Mathalon DH; Ahn KH; Perry EB; Cho HS; Roach BJ; Blais RK; Bhakta S; Ranganathan M; Ford JM; D'Souza DC
Front Psychiatry; 2014; 5():3. PubMed ID: 24478731
[TBL] [Abstract][Full Text] [Related]
2. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
3. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
[TBL] [Abstract][Full Text] [Related]
4. Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.
Knott V; Shah D; Millar A; McIntosh J; Fisher D; Blais C; Ilivitsky V
Front Pharmacol; 2012; 3():172. PubMed ID: 23060793
[TBL] [Abstract][Full Text] [Related]
5. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-d-aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Carroll B; Ilivitsky V; Knott V
Pharmacol Biochem Behav; 2021 Dec; 211():173287. PubMed ID: 34653398
[TBL] [Abstract][Full Text] [Related]
7. Glutamatergic modulation of auditory information processing in the human brain.
Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
[TBL] [Abstract][Full Text] [Related]
8. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission.
Watson TD; Petrakis IL; Edgecombe J; Perrino A; Krystal JH; Mathalon DH
Int J Neuropsychopharmacol; 2009 Apr; 12(3):357-70. PubMed ID: 18771605
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
[TBL] [Abstract][Full Text] [Related]
12. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
[TBL] [Abstract][Full Text] [Related]
14. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study.
Mathalon DH; Ford JM; Pfefferbaum A
Biol Psychiatry; 2000 Mar; 47(5):434-49. PubMed ID: 10704955
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
[TBL] [Abstract][Full Text] [Related]
16. Baseline-dependent modulating effects of nicotine on voluntary and involuntary attention measured with brain event-related P3 potentials.
Knott V; Choueiry J; Dort H; Smith D; Impey D; de la Salle S; Philippe T
Pharmacol Biochem Behav; 2014 Jul; 122():107-17. PubMed ID: 24690514
[TBL] [Abstract][Full Text] [Related]
17. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
18. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
19. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
20. Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes.
Rosburg T; Schmidt A
Front Behav Neurosci; 2018; 12():308. PubMed ID: 30618662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
